首页> 外文期刊>Systematic Reviews >A comparison of quality of abstracts of systematic reviews including meta-analysis of randomized controlled trials in high-impact general medicine journals before and after the publication of PRISMA extension for abstracts: a systematic review and meta-analysis
【24h】

A comparison of quality of abstracts of systematic reviews including meta-analysis of randomized controlled trials in high-impact general medicine journals before and after the publication of PRISMA extension for abstracts: a systematic review and meta-analysis

机译:对系统评论摘要质量的比较,包括在摘要出版前后的高碰撞通用医学期刊中的随机对照试验的荟萃分析:系统审查和荟萃分析

获取原文
       

摘要

Background Journal s including those reporting systematic reviews (SR) should contain sufficiently clear and accurate information for adequate comprehension and interpretation. The aim was to compare the quality of reporting of s of SRs including meta-analysis published in high-impact general medicine journals before and after publication of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for s (PRISMA-A) released in April 2013. Methods SRs including meta-analysis of randomized controlled trials published in 2012, 2014, and 2015 in top-tier general medicine journals were searched in PubMed. Data was selected and extracted by two reviewers based on the PRISMA-A guidelines which recommend to include 12 items. The primary outcome was the adjusted mean number of items reported; the secondary outcome was the reporting of each item and factors associated with a better reporting. Adjustment was made for word count and format, number of authors, PRISMA endorsement, and publication on behalf of a group. Results We included 84 s from 2012, 59 from 2014, and 61 from 2015. The mean number of items reported in 2015 (7.5; standard deviation [SD] 1.6) and in 2014 (6.8; SD 1.6) differed and did not differ from that reported in 2012 (7.2; SD 1.7), respectively; adjusted mean difference: 0.9 (95 % CI 0.4; 1.3) and??0.1 (95 % CI ?0.6; 0.4). From 2012 to 2014, the quality of reporting was in regression for “strengths and limitations of evidence” and “funding”; contrariwise, it remained unchanged for the others items. Between 2012 and 2015, the quality of reporting rose up for “description of the effect”, “synthesis of results”, “interpretation”, and “registration”; but decreased for “strengths and limitations of evidence”; it remained unchanged for the other items. The overall better reporting was associated with s structured in the 8-headings format in 2014 and s with a word count Conclusions Not surprisingly, the quality of reporting did not improve in 2014 and suboptimally improved in 2015. There is still room for improvement to meet the standards of PRISMA-A guidelines. Stricter adherence to these guidelines by authors, reviewers, and journal editors is highly warranted and will surely contribute to a better reporting.
机译:背景日志包括那些报告系统评论(SR)应含有足够明确和准确的信息,以充分理解和解释。该目的是比较SRS的报告质量,包括在发布在发布的高影响常规医学期刊之前和之后发表的Meta分析,该期刊出版了关于S的首选报告项目(PRISMA-)的首选报告项目(PRISMA- a)于2013年4月发布。方法在PubMed中搜索了2012年2012年2012年和2015年出版的随机对照试验的荟萃分析的SRS。由两位审阅者选择并提取数据,基于PRISMA-A指南,建议包括12项。主要结果是报告的调整后的项目数;次要结果是报告每个项目和因素与更好的报告相关。调整是针对单词计数和格式,作者数量,PRISMA认可和发布代表一组。结果我们从2012年的2012年纳入了84秒,从2014年起,从2015年起,从2015年开始61个。2015年报告的项目的平均数量(7.5;标准差[SD] 1.6),2014年(6.8; SD 1.6)不同,与之不同2012年报告(7.2; SD 1.7)报告;调整后平均差异:0.9(95%CI 0.4; 1.3)和?? 0.1(95%CI?0.6; 0.4)。从2012年到2014年,报告质量是回归“证据的优势和局限性”和“资金”;相比之下,其他物品保持不变。 2012年至2015年间,报告质量上涨了“效果的描述”,“结果综合”,“解释”和“注册”;但“证据的优势和局限性”减少;它对其他物品保持不变。整体更好的报告与2014年8号格式中的S结构相关联,并毫不奇怪的单词结论,2014年报告质量并未改善,2015年逐步改善。仍然有所改善Prisma-A指南的标准。受到作者,审稿人和期刊编辑对这些准则的更严格遵守这些指导方针,并且肯定会促成更好的报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号